Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate

Chemical Research in Toxicology

Volumn 13, Issue 4, 2000, Pages 231-236

  Tzeng, Huey Fen ^a,c   Blackburn, Anneke C ^b,d   Board, Philip G ^d   Anders, M W ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; DICHLOROACETIC ACID; GLUTATHIONE TRANSFERASE;

ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CATALYSIS; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME POLYMORPHISM; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PROTEIN MODIFICATION;

ANIMALS; DICHLOROACETATE; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; LIVER; MALE; MICE; POLYMORPHISM, GENETIC; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; SPECIES SPECIFICITY;

ANIMALIA;

EID: 0034053786     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990175q     Document Type: Article

References (33)

1. Board, P. G., Baker, R. T., Chelvanayagam, G., and Jermiin, L. S. ( 1997) Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem. J. 328, 929-935.
2. Tong, Z., Board, P. G., and Anders, M. W. (1998) Glutathione transferase Zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem. J. 331, 371-374.
3. Tong, Z., Board, P. G., and Anders, M. W. (1998) Glutathione transferase Zeta-catalyzed biotransformation of dichloroacetic acid and other α-haloacids. Chem. Res. Toxicol. 11, 1332-1338.
4. Fernández-Cañón, J. M., and Peñalva, M. A. (1998) Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J. Biol. Chem. 273, 329-337.
5. Board, P., Blackburn, A., Jermiin, L. S., and Chelvanayagam, G. (1998) Polymorphism of phase II enzymes: identification of new enzymes and polymorphic variants by database analysis. Toxicol. Lett. 102-103, 149-154.
6. Blackburn, A. C., Woollatt, E., Sutherland, G. R., and Board, P. G. (1998) Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase. Cytogenet. Cell Genet. 83, 109-114.
7. Blackburn, A. C., Tzeng, H.-F., Anders, M. W., and Board, P. G. (1999) Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics (in press).
8. Krasner, S. W., McGuire, M. J., Jacangelo, J. G., Patania, N. L., Reagan, K. M., and Aieta, E. M. (1989) The occurrence of disinfection by-products in U.S. drinking water. J. Am. Water Works Assoc. 81, 41-53.
9. Weisel, C. P., Kim, H., Haltmeier, P., and Klotz, J. B. (1998) Exposure estimates to disinfection by-products of chlorinated drinking water. Environ. Health Perspect. 107, 103-110.
10. Herren-Freund, S. L., Pereira, M. A., Khoury, M. D., and Olson, G. (1987) The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90, 183-189.
11. Bull, R. J., Sanchez, I. M., Nelson, M. A., Larson, J. L., and Lansing, A. J. (1990) Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63, 341-359.
12. DeAngelo, A. B., Daniel, F. B., Stober, J. A., and Olson, G. R. (1991) The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16, 337-347.
13. DeAngelo, A. B., Daniel, F. B., Most, B. M., and Olson, G. R. (1996) The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114, 207-221.
14. +/ -3.7.2C mouse lymphoma cells. Mutat. Res. 413, 265-276.
15. Tao, L., Kramer, P. M., Ge, R., and Pereira, M. A. (1998) Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver and tumors of female B6C3F1 mice. Toxicol. Sci. 43, 139-144.
16. Stacpoole, P. W., Henderson, G. N., Yan, Z. M., and James, M. O. (1998) Clinical pharmacology and toxicology of dichloroacetate. Environ. Health Perspect. 106 (Suppl. 4), 989-994.
17. Curry, S. H., Chu, P.-I., Baumgartner, T. G., and Stackpoole, P. W. (1985) Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin. Pharmacol. Ther. 37, 89-93.
18. Curry, S. H., Lorenz, A., Chu, P.-I., Limacher, M., and Stacpoole, P. W. (1991) Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Biopharm. Drug Dispos. 12, 375-390.
19. James, M. O., Cornett, R., Yan, Z., Henderson, G. N., and Stacpoole, P. W. (1997) Glutathione-dependent conversion to glyoxylate, a major metabolite of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats. Drug Metab. Dispos. 25, 1223-1227.
20. Anderson, W. B., Board, P. G., Gargano, B., and Anders, M. W. (1999) Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking α-haloalkanoic acids. Chem. Res. Toxicol. 12, 1144-1149.
21. Silverman, R. B. (1995) Mechanism-based enzyme inactivators. Methods Enzymol. 249, 240-283.
22. Cornett, R., James, M. O., Henderson, G. N., Cheung, J., Shroads, A. L., and Stacpoole, P. W. (1999) Inhibition of glutathione S-transferase ζ and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity. Biochem. Biophys. Res. Commun. 262, 752-756.
23. Wempe, M. F., Anderson, W. B., Tzeng, H.-F., Board, P. G., and Anders, M. W. (1999) Glutathione transferase zeta-catalyzed biotransformation of deuterated dihaloacetic acids. Biochem. Biophys. Res. Commun. 261, 779-783.
24. Brodwell, F. G., Cooper, G. D., and Morita, H. (1957) The hydrolysis of chloromethyl aryl sulfides. J. Am. Chem. Soc. 79, 376-378.
25. Peach, M. E. (1974) Thiols as nucleophiles. In The Chemistry of the Thiol Group (Patai, S., Ed.) pp 722-784, Wiley, New York.
26. Mitchell, G. A., Lambert, M., and Tanquay, R. M. (1995) Hypertyrosinemia. In The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W., and Vallee, D., Eds.) pp 1077-1106, McGraw-Hill, New York.
27. Tanguay, R. M., Jorquera, R., Poudrier, J., and St-Louis, M. (1996) Tyrosine and its catabolites: from disease to cancer. Acta Biochim. Pol. 43, 209-216.
28. Jorquera, R., and Tanguay, R. M. (1997) The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. Biochem. Biophys. Res. Commun. 232, 42-48.
29. Lindstedt, S., Holme, E., Lock, E. A., Hjalmarson, O., and Strandvik, B. (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340, 813-817.
30. Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kennaway, N. G., Papaconstantinou, J., Torres-Ramos, C. A., Ou, C.-N., and Finegold, M. (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat. Genet. 10, 453-460.
31. Grompe, M., Overturf, K., al-Dhalimy, M., and Finegold, M. (1998) Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J. Inherited Metab. Dis. 21, 518-531.
32. Stacpoole, P. W., Barnes, C. L., Hurbanis, M. D., Cannon, S. L., and Kerr, D. S. (1997) Treatment of congenital lactic acidosis with dichloroacetate. Arch. Dis. Child. 77, 535-541.
33. Stacpoole, P. W., Henderson, G. N., Yan, Y., Cornett, R., and James, M. O. (1998) Pharmacokinetics, metabolism, and toxicology of dichloroacetate. Drug Metab. Rev. 30, 499-539.